Comparison of the Clinical Efficacy and Safety Between Raloxifene and Bazedoxifene in Postmenopausal Women.
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2018
Price : $35 *
At a glance
- Drugs Bazedoxifene (Primary) ; Raloxifene (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 18 Oct 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 08 Nov 2013 New trial record